DexCom
Trade DexCom 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About DXCM
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.
DXCM Key Statistics
Stock Snapshot
DexCom(DXCM) stock is priced at $71.80, giving the company a market capitalization of 27.74B. It carries a P/E multiple of 30.55.
On 2026-05-21, DexCom(DXCM) stock moved within a range of $70.18 to $72.27. With shares now at $71.80, the stock is trading +2.3% above its intraday low and -0.7% below the session's peak.
Trading volume for DexCom(DXCM) stock has reached 9.08M, versus its average volume of 8.32M.
The stock's 52-week range extends from a low of $54.11 to a high of $89.98.
The stock's 52-week range extends from a low of $54.11 to a high of $89.98.
DXCM News
In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, DexCom Inc (Symbol: DXCM) has taken over the #331 spot...
DexCom (NasdaqGS:DXCM) has launched Dexcom Flex, a continuous glucose monitoring system for adults with Type 2 diabetes in Germany. The system is aimed at pati...
DexCom DXCM recently announced the launch of Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for adults with Type 2 diabetes who are not...
Analyst ratings
84%
of 32 ratingsMore DXCM News
DexCom (DXCM) announced Dexcom Flex, a new CGM system designed specifically for adults with Type 2 diabetes who are not using intensive insulin therapy. The new...
DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose...
Wondering if DexCom at around US$61.63 is starting to look interesting again, or if the stock still carries too much downside risk for your portfolio? The shar...
Company Highlights Long-Term Margin Expansion Goals The diabetes technology company in an SEC filing said it expects organic revenue growth of more than 10% an...
Dexcom (DXCM) stock jumped about 8% on Friday, at the time of writing, as activist investor Elliott Investment Management took a stake in the maker of continuou...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Earlier this month, DexCom outlined governance changes ahead of its 2026 Investor Day, agreeing with Elliott Investment Management to recruit two new independen...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.